Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.90−0.10 (-3.33%)
Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –
Nephros price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nephros's price to sales ratio was 1.6× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 0.9× to 6.1×, with a median of 1.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.6× | −1.3 |
| 2025 | Dec 31, 2025 | 2.9× | +1.7 |
| 2024 | Dec 31, 2024 | 1.1× | −1.5 |
| 2023 | Dec 29, 2023 | 2.7× | +1.5 |
| 2022 | Dec 30, 2022 | 1.2× | −4.9 |
| 2021 | Dec 31, 2021 | 6.1× | −2.2 |
| 2020 | Dec 31, 2020 | 8.3× | −0.6 |
| 2019 | Dec 31, 2019 | 8.8× | +2.0 |
| 2018 | Dec 31, 2018 | 6.8× | −0.7 |
| 2017 | Dec 29, 2017 | 7.5× | −1.8 |
| 2016 | Dec 30, 2016 | 9.3× | +5.6 |
| 2015 | Dec 31, 2015 | 3.7× | −8.6 |
| 2014 | Dec 31, 2014 | 12.2× | +8.2 |
| 2013 | Dec 31, 2013 | 4.0× | −3.2 |
| 2012 | Dec 31, 2012 | 7.2× | +4.1 |
| 2011 | Dec 30, 2011 | 3.1× | – |
See a number that looks wrong?